We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$5.38M
Cap. Flow
-$5.42M
Cap. Flow %
-4.55%
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.8M
2
WBA
Walgreens Boots Alliance
WBA
+$1.67M
3
BIDU icon
Baidu
BIDU
+$1.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.53M
5
BABA icon
Alibaba
BABA
+$1.47M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$14.8M
2
NHC icon
National Healthcare
NHC
+$2.77M
3
TAST
Carrols Restaurant Group, Inc.
TAST
+$2.76M
4
FCX icon
Freeport-McMoran
FCX
+$2.13M
5
BGC icon
BGC Group
BGC
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 42.71%
2 Industrials 9.53%
3 Technology 8.54%
4 Materials 8.18%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALCO icon
1
Alico
ALCO
$300M
$6.3M 5.29%
215,000
– –
TGB
2
Trekor Metals
TGB
$3.36B
$5.42M 4.56%
2,500,000
– –
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
$5.3M 4.45%
450,000
– –
RPRX icon
4
Royalty Pharma
RPRX
$27.1B
$4.86M 4.08%
160,000
+35,000
+28% +$1.03M
NMRK icon
5
Newmark Group
NMRK
$2.87B
$4.44M 3.73%
400,000
– –
RLGT icon
6
Radiant Logistics
RLGT
$408M
$3.93M 3.3%
725,000
+35,000
+5% +$208K
IOVA icon
7
Iovance Biotherapeutics
IOVA
$3.63B
$3.71M 3.11%
250,000
– –
AMSC icon
8
American Superconductor
AMSC
$1.38B
$3.38M 2.84%
250,000
+55,000
+28% +$682K
PLPC icon
9
Preformed Line Products
PLPC
$1.98B
$3.35M 2.81%
26,000
+8,500
+49% +$1.09M
KD icon
10
Kyndryl
KD
$2.88B
$3.05M 2.56%
140,000
– –
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
$3.04M 2.55%
140,000
+75,000
+115% +$1.67M
INTT icon
12
inTEST
INTT
$142M
$2.98M 2.5%
225,000
+105,000
+88% +$1.24M
RIGL icon
13
Rigel Pharmaceuticals
RIGL
$868M
$2.96M 2.49%
200,000
+30,000
+18% +$404K
PD icon
14
PagerDuty
PD
$1.09B
$2.72M 2.29%
120,000
– –
CLPT icon
15
ClearPoint Neuro
CLPT
$474M
$2.55M 2.14%
375,000
+175,000
+88% +$1.22M
ARKR icon
16
Ark Restaurants
ARKR
$19.8M
$2.54M 2.13%
184,607
– –
BGC icon
17
BGC Group
BGC
$5.76B
$2.53M 2.12%
325,000
-250,000
-43% -$1.85M
CHRS icon
18
Coherus Oncology
CHRS
$218M
$2.39M 2.01%
1,000,000
+176,000
+21% +$433K
VTRS icon
19
Viatris
VTRS
$18.8B
$2.39M 2.01%
200,000
– –
OGN icon
20
Organon & Co
OGN
$3.61B
$2.35M 1.97%
125,000
– –
EOLS icon
21
Evolus
EOLS
$587M
$2.1M 1.76%
150,000
– –
SVC
22
Service Properties Trust
SVC
$1.02B
$2.03M 1.71%
60,000
+10,000
+20% +$371K
ARKO icon
23
ARKO Corp
ARKO
$490M
$2.02M 1.7%
720,000
+110,000
+18% +$803K
BRKL
24
DELISTED
Brookline Bancorp
BRKL
$1.79M 1.51%
180,000
– –
WBD icon
25
Warner Bros
WBD
$72.1B
$1.75M 1.47%
200,000
+75,000
+60% +$723K
1
2 3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q1 2024 Portfolio in Review

As of Q1 2024, CM Management held 80 positions worth $119M, down 4.3% from $124M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management withdrew a net $5.42M in Q1 2024, closing 11 positions and reducing 7 holdings. Its most notable exit was Immunogen Inc, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, CM Management opened a new position in Incyte worth $1.71M.

  • CM Management's largest Q1 2024 buy was Incyte: 30,000 shares worth $1.71M.
  • CM Management added most to Walgreens Boots Alliance in Q1 2024, an estimated $1.67M increase.
  • CM Management's biggest Q1 2024 reduction was BGC Group, cutting an estimated $1.85M.
  • CM Management fully exited Immunogen Inc in Q1 2024, selling an estimated $14.8M.
  • CM Management's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
  • CM Management opened 8 new positions and closed 11 in Q1 2024.
  • CM Management's portfolio value fell 4.3% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.